id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0030-0006,FDA,FDA-2010-E-0030,"U.S. Patent and Trademark Office to Southern Research Institute, Sloan-Kettering Institute for Cancer Research, and SRI International  (Larson & Anderson LLC) - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T16:03:56Z,,0,0,09000064812bdde6
FDA-2010-E-0030-0005,FDA,FDA-2010-E-0030,Regulatory Review Periods for Purposes of Patent Extensions; Determinations: FOLOTYN,Notice,N-Notice,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,2011-02-19T04:59:59Z,2010-12-20T15:54:26Z,2010-31846,0,0,0900006480bba892
FDA-2010-E-0030-0004,FDA,FDA-2010-E-0030,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-06-22T04:00:00Z,2010,6,2010-06-22T04:00:00Z,,2010-06-22T12:31:43Z,,0,0,0900006480b07d1f
FDA-2010-E-0030-0003,FDA,FDA-2010-E-0030,FDA/CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:51Z,,0,0,0900006480ab52c9
FDA-2010-E-0030-0002,FDA,FDA-2010-E-0030,"Southern Research Institute, Sloan-Kettering Institute for Cancer Research, and SRI International - Patent Term Extension Application",Other,APP-Application,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-07-27T23:04:32Z,,0,0,0900006480a7ddde
FDA-2010-E-0030-0001,FDA,FDA-2010-E-0030,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-08-11T04:37:25Z,,0,0,0900006480a7dddc